Page last updated: 2024-12-10
17-methylandrost-2-en-17-ol
Description
17-methylandrost-2-en-17-ol is a synthetic steroid that is structurally related to testosterone. It's important for research because:
**1. It's a potent androgen receptor (AR) agonist:** This means it binds to and activates the AR, which is a protein involved in the development and function of male sexual characteristics. This makes it useful in studying the role of AR in various physiological and pathological processes.
**2. It's a potential therapeutic agent:** Due to its potent androgenic activity, it has been explored as a potential treatment for conditions like hypogonadism (low testosterone) and muscle wasting.
**3. It's a valuable research tool:** 17-methylandrost-2-en-17-ol serves as a valuable tool for researchers investigating:
* **The role of AR in various tissues and conditions:** It can help determine the involvement of AR in different diseases and the potential for targeting AR to develop new therapies.
* **The mechanisms of action of AR agonists:** It can be used to study how AR agonists work at the molecular level and to identify new targets for drug development.
* **The development of novel androgenic drugs:** Its structure and activity provide a starting point for the design of new androgenic drugs with improved efficacy and safety profiles.
**However, it's important to note:**
* 17-methylandrost-2-en-17-ol is not currently approved for therapeutic use in humans.
* Its use in research is regulated and requires careful consideration of its potential risks and benefits.
**Further research is ongoing to explore the full therapeutic potential and safety profile of 17-methylandrost-2-en-17-ol.**
17-methylandrost-2-en-17-ol: a designer steroid; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 4010235 |
MeSH ID | M0484630 |
Synonyms (3)
Synonym |
NCIOPEN2_002832 |
DTXSID10863143 |
17-methylandrost-2-en-17-ol |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.21
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.21 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.51 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 2 (22.22%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (77.78%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |